Verastem (VSTM) Financials: Revenue & Earnings

VSTM price $10.10 -0.01 -0.05%

Ticker
VSTM
Price
$10.10
Change
-0.01 -0.05%
Market cap ?
$914.24M
P/E ?
-4.08
Forward P/E ?
23.39
Dividend yield ?
0.00%
Beta ?
0.32
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
44
Quality
45
Growth
97

Stocklytics score rationale: value 44, quality 45, growth 97.

Financials

2016201720182019202020212022202320242025
002671800017456000885160002053000259600001000000030914000

Verastem, Inc. is an emerging biopharmaceutical company dedicated to the creation and commercialization of innovative therapeutic agents for cancer treatment. A primary asset in its pipeline is VS-6766, a novel dual RAF/MEK inhibitor that operates by a "clamp" mechanism. This unique action effectively blocks the kinase activity of MEK and disrupts RAF's ability to phosphorylate MEK. The company is actively advancing…

Fair value

VSTM fair value $9.56. Price $10.10. Price is 6% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.59M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 90.56M. Net debt -128.12M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare VSTM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.44—26.57M
2026-08-06-0.35-0.4340.08M22.88M
2026-05-07-0.37-0.4618.67M21.43M
2026-03-04-0.39-0.4917.54M16.90M
2025-11-04-1.35-0.5111.24M16.53M
2025-08-07-0.39-0.852.14M5.70M
2025-05-13-0.96-0.72—100.00K
2025-03-20-1.33-0.819.98M150.00K
2024-11-06-0.60-0.71—133.33K
2024-08-08-0.31-1.0610.00M50.00K
2024-05-09-1.26-1.16——
2024-03-14-1.02-0.82114.00K5.09M
2023-11-08-0.75-0.92—5.09M
2023-08-08-1.37-1.13—20.00K
2023-05-09-0.96-1.08—20.00K
2023-03-14-0.960.102.60M—
2022-11-03-1.08-1.44——
2022-08-08-1.44-1.32——
2022-05-09-1.08-0.962.60M1.50M
2022-03-28-1.08-0.96545.00K50.00K
2021-11-04-1.56-1.082.00K1.83K
2021-08-02-1.20-1.08500.00K50.00K
2021-05-11-1.08-1.081.01M1.01M
2021-03-18-1.44—506.00K—
2020-11-090.963.3678.65M86.51M
2020-08-10-1.68-1.804.31M4.61M
2020-05-07-4.20-2.285.06M3.18M
2020-03-11-6.12-0.453.62M3.19M
2019-10-29-4.20-5.049.03M10.13M
2019-08-01-5.76-5.883.14M2.75M
2019-05-09-6.12-5.521.67M1.48M
2019-03-12-4.44-6.481.21M4.28M
2018-11-07-3.48-5.1615.51M22.46M
2018-08-08-3.60-4.2010.00M11.33M
2018-05-03-4.92-4.92——
2018-03-13-5.16-4.56——
2017-11-07-7.32-3.84——
2017-08-08-4.32-4.08——
2017-05-10-4.20-4.32——
2017-03-23-3.84-3.24——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Paterson DanSell44.12K$8.00352.97K
2026-10-01Calkins DanielSell2.57K$8.0020.53K
2026-09-30Paterson DanSell106.89K——
2026-09-30Calkins DanielSell8.33K——
2026-09-21Calkins DanielSell55$7.70424
2026-08-03Paterson DanSell1.30K$5.817.56K
2026-06-22Paterson DanSell20.87K$4.1887.24K
2026-06-22Calkins DanielSell4.03K$4.1816.85K
2026-06-22Calkins DanielSell57$4.13235
2026-05-21BAILEY MICHAEL PBuy108.00K——
2026-05-21BAILEY MICHAEL POther0——
2026-05-21Tollefson Karin AnnaBuy36.00K——
2026-05-21Stuglik Brian MBuy36.00K——
2026-05-21Rowinsky Eric KBuy36.00K——
2026-05-21ROBERTSON MICHELLEBuy36.00K——
2026-05-21Kapur AnilBuy36.00K——
2026-05-21Bunn Paul A.Buy36.00K——
2026-05-21JOHNSON JOHNBuy36.00K——
2026-05-04Paterson DanSell806$5.824.69K
2026-03-20Calkins DanielSell57$5.74327
2026-02-04Paterson DanSell970$6.696.49K
2026-01-21Calkins DanielBuy16.66K——
2026-01-21Paterson DanBuy213.78K——
2026-01-12Paterson DanSell10.32K$7.1673.90K
2026-01-12Calkins DanielSell5.04K$7.1636.08K
2026-01-06Kauffman MichaelBuy200.00K$6.881.38M
2025-12-24Calkins DanielSell80$7.86629
2025-12-16Stuglik Brian MSell592$9.145.41K
2025-12-16Paterson DanSell393$9.143.59K
2025-12-16Gagnon Robert E.Sell283$9.142.59K
2025-12-11Paterson DanSell2.00K$10.0020.00K
2025-12-10Paterson DanSell2.00K$10.0720.14K
2025-12-09Paterson DanSell2.00K$10.2520.50K
2025-12-08Paterson DanSell2.00K$10.5021.00K
2025-12-05Paterson DanSell2.00K$10.6121.22K
2025-12-04Paterson DanSell2.00K$10.0020.00K
2025-12-03Paterson DanSell2.00K$10.0020.00K
2025-12-02Paterson DanSell2.00K$10.3220.64K
2025-12-01Paterson DanSell2.00K$10.3920.78K
2025-11-28Paterson DanSell2.00K$10.7921.58K
2025-11-26Paterson DanSell2.00K$10.3220.64K
2025-11-25Paterson DanSell2.00K$10.0020.00K
2025-11-24Paterson DanSell2.00K$10.0020.00K
2025-11-21Bunn Paul A.Buy6.25K$3.2720.44K
2025-11-21Bunn Paul A.Sell6.25K$3.2720.44K
2025-11-21Bunn Paul A.Sell6.25K$10.0062.50K
2025-11-21Kauffman MichaelSell8.55K$10.0085.50K
2025-11-21Paterson DanSell2.00K$10.0020.00K
2025-11-03Paterson DanSell1.30K$9.3512.15K
2025-11-03Paterson DanSell2.00K$10.0020.00K
2025-10-09Bunn Paul A.Sell8.33K$9.0675.50K
2025-09-24Calkins DanielSell25$9.23231
2025-09-22Calkins DanielSell57$9.08518
2025-09-16Stuglik Brian MSell587$9.995.86K
2025-09-16Gagnon Robert E.Sell281$9.992.81K
2025-09-16Paterson DanSell390$9.993.90K
2025-08-06Paterson DanSell1.33K$5.817.74K
2025-06-23Calkins DanielSell25$4.71118
2025-06-20Paterson DanSell17.81K$5.1391.36K
2025-06-20Calkins DanielSell4.11K$5.1321.08K
2025-06-16Paterson DanSell335$5.651.89K
2025-06-16Gagnon Robert E.Sell284$5.651.60K
2025-06-16Stuglik Brian MSell594$5.653.36K
2025-05-22ROBERTSON MICHELLEBuy8.33K——
2025-05-22ROBERTSON MICHELLEBuy12.50K$7.4893.50K
2025-05-22Bunn Paul A.Buy8.33K——
2025-05-22Bunn Paul A.Buy12.50K$7.4893.50K
2025-05-22Kapur AnilBuy8.33K——
2025-05-22Kapur AnilBuy12.50K$7.4893.50K
2025-05-22Stuglik Brian MBuy8.33K——
2025-05-22Stuglik Brian MBuy12.50K$7.4893.50K
2025-05-22Gagnon Robert E.Buy8.33K——
2025-05-22Gagnon Robert E.Buy12.50K$7.4893.50K
2025-05-22Kauffman MichaelBuy8.33K——
2025-05-22Kauffman MichaelBuy12.50K$7.4893.50K
2025-05-22Tollefson Karin AnnaBuy8.33K——
2025-05-22Tollefson Karin AnnaBuy12.50K$7.4893.50K
2025-05-22JOHNSON JOHNBuy8.33K——
2025-05-22JOHNSON JOHNBuy12.50K$7.4893.50K
2025-05-22Rowinsky Eric KBuy8.33K——
2025-05-22Rowinsky Eric KBuy12.50K$7.4893.50K
2025-05-20Calkins DanielSell11.14K$8.1390.59K
2025-05-20Paterson DanSell58.68K$8.13477.04K
2025-05-16Calkins DanielSell38.85K——
2025-05-16Paterson DanSell150.00K——
2025-05-16Paterson DanSell25.00K——
2025-05-05Paterson DanSell820$7.305.99K
2025-04-01Ros MatthewBuy50.00K——
2025-03-24Calkins DanielSell26$7.04183
2025-03-20Calkins DanielSell65$6.89448
2025-03-17Paterson DanSell244$6.951.70K
2025-03-17Gagnon Robert E.Sell284$6.951.97K
2025-03-17Stuglik Brian MSell593$6.954.12K
2025-02-04Paterson DanSell858$5.704.89K
2025-01-14Ros MatthewOther0——
2025-01-13Paterson DanSell8.57K$5.2444.90K
2025-01-10Paterson DanBuy25.00K——
2025-01-10Paterson DanBuy100.00K——
2025-01-10Calkins DanielBuy38.80K——
2025-01-06Calkins DanielSell6$6.9442

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 167, holders +5 vs prior quarter. Ownership 95.26%.

HolderSharesChangeChange %Value
BLACKROCK, INC.9.19M3.00M+48.39%35.12M
ARMISTICE CAPITAL, LLC7.02M2.43M+52.96%26.83M
RTW INVESTMENTS, LP6.64M59.49K+0.90%25.35M
DEEP TRACK CAPITAL, LP5.74M00.00%21.93M
STATE STREET CORP5.13M1.62M+45.99%19.61M
ROSALIND ADVISORS, INC.3.99M1.85M+86.42%15.23M
VANGUARD CAPITAL MANAGEMENT LLC3.85M528.74K+15.91%14.71M
NANTAHALA CAPITAL MANAGEMENT, LLC3.58M00.00%13.69M
STONEPINE CAPITAL MANAGEMENT, LLC3.35M47.33K+1.43%12.80M
VANGUARD PORTFOLIO MANAGEMENT LLC3.27M2.51M+331.63%12.48M
FORESITE CAPITAL MANAGEMENT VI LLC3.15M00.00%12.02M
GOLDMAN SACHS GROUP INC2.72M1.24M+83.37%10.39M
BAKER BROS. ADVISORS LP2.50M1.91M+327.41%9.55M
ALYESKA INVESTMENT GROUP, L.P.2.29M239.62K+11.69%8.75M
MILLENNIUM MANAGEMENT LLC2.08M-333.96K-13.85%7.94M
GEODE CAPITAL MANAGEMENT, LLC2.07M356.59K+20.76%7.93M
AIGH CAPITAL MANAGEMENT LLC1.93M-73.00K-3.65%7.36M
OPALEYE MANAGEMENT INC.1.80M1.80MNew6.88M
BALYASNY ASSET MANAGEMENT L.P.1.69M1.28M+311.58%6.44M
QUBE RESEARCH & TECHNOLOGIES LTD1.63M152.46K+10.33%6.22M
ACORN CAPITAL ADVISORS, LLC1.47M00.00%5.61M
NEXTBIO CAPITAL MANAGEMENT LP1.31M00.00%4.99M
FRANKLIN TEMPLETON INC1.11M-864-0.08%4.22M
PINNACLE FINANCIAL PARTNERS, INC.1.09M591.17K+119.36%4.15M
AQR CAPITAL MANAGEMENT LLC934.57K868.50K+1314.61%3.57M

Earnings and financials

Verastem, Inc. (VSTM) trades at $10.10, with a market cap of $914.24M and a trailing P/E of -4.08. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
002671800017456000885160002053000259600001000000030914000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Verastem (VSTM) Financials: Revenue & Earnings

VSTM$10.10-0.01 -0.05%

$914.24M

Market Cap

-4.08

P/E

23.39

Forward P/E

62

Score

Price History